GJA1 and ventricular tachycardia: Interestingly, Cx43 gene transfer or engraftment of Cx43-expressing cells reduces the susceptibility to ventricular tachycardia (VT) in different animal models, providing an important proof of concept for the antiarrhythmic effects of targeting the mechanisms underlying slow conduction (147–149).